Recruiting
A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL Patients
NCT07671378
- Conditions
- CLL (Chronic Lymphocytic Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China